PF-00562271: Clinical Trials

1 trial of PF-00562271, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PF-00562271: new trials by email Literature Review of PF-00562271 trials Research Report on PF-00562271

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
PF00562271 - Head and Neck Neoplasm, Prostatic Neoplasm
Phase 1CompletedVerastem, Inc.992005-12-012013-03-21

Conditions studied

Head and Neck Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)

Sponsors

Verastem, Inc. (1)

Countries

Australia (1)  ·  Canada (1)  ·  United States (1)